Han, K., Chon, S., Chung, C. H., Lim, S., Lee, K., Baik, S., . . . Lee, M. (2018). Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial. Diabetes Obes Metab.
Chicago Style aipamenaHan, Kyung‐Ah, et al. "Efficacy and Safety of Ipragliflozin As an Add‐on Therapy to Sitagliptin and Metformin in Korean Patients With Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized Controlled Trial." Diabetes Obes Metab 2018.
MLA aipamenaHan, Kyung‐Ah, et al. "Efficacy and Safety of Ipragliflozin As an Add‐on Therapy to Sitagliptin and Metformin in Korean Patients With Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized Controlled Trial." Diabetes Obes Metab 2018.